Full results from a randomized controlled trial (RCT) suggest that the over-the-counter (OTC) antihistamine clemastine fumarate is safe and effective for treating chronic demyelinating injury in ...

Researchers added a treatment arm to an ongoing study of nine patients with MS who were given clemastine fumarate. The treatment was halted when three patients experienced exponential disability ...

Researchers halted an arm of a clinical trial of clemastine fumarate for MS after a fivefold increase in disease progression was reported in three participants, triggering "stoppage criteria ...

In 2014, studies carried out by Prof. Jonah R. Chan at the University of California, San Francisco showed that clemastine fumarate may be a candidate for the treatment of MS. Because of the ...

One of these compounds, clemastine fumarate, is licensed for treatment of allergic conditions. We tested whether clemastine fumarate can promote myelination in two rodent PMD models, the myelin ...

Researchers from the University of California, San Francisco, completed the clinical trial of the U.S. Food and Drug Administration-approved antihistamine clemastine fumarate on patients with MS ...